Lori G. Cohen has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. Lori is National Counsel for a medical device manufacturer, handling its litigation including class actions, multidistrict litigation, and trials nationally. She has served as both National Counsel and Regional Counsel for pharmaceutical and medical device companies and has expertise in mass tort, multidistrict and class action litigation. She also has vast experience in other products liability litigation and jury trials of all kinds. She has defended numerous health care providers, including physicians, hospitals and managed care entities nationwide.
Lori has obtained 56 defense verdicts at trial. During recent years, she obtained defense verdicts as a result of a two-month trial with $30 million in alleged damages involving a laser-resistant endotracheal tube against a medical device manufacturer; a three-month trial with $78 million in alleged damages against the world's leading manufacturer of pacemakers; a four-week trial with $20 million in alleged damages involving an implantable neurostimulation device; a four-week trial with $18 million in alleged damages involving three consolidated cases against the manufacturer of a continuous local anesthesia infusion drug pump; a three-week medical malpractice trial in which she represented OB/GYN clients; and a three-week medical malpractice trial for a hospital involving allegations of an overdose on a patient controlled analgesia (PCA) pump.
Lori has been profiled in Law360’s 2012 "Top Female Trial Attorneys," the Financial Times and The National Law Journal’s "Winning - Successful Strategies From Some of the Nation’s Top Litigators," a special report recognizing ten attorneys from across the U.S. She has been recognized by The National Law Journal as one of "The 50 Most Influential Women Lawyers in America." The National Law Journal has recognized two of her defense trial victories as "Top Defense Wins" in recent years, and she has been featured in The National Law Journal’s "Top 40 Under 40," which highlights the 40 most successful litigators under the age of 40 in the country. She is listed in The Best Lawyers in America, The Legal 500 United States, The Legal 500 "Leading Trial Lawyers," Chambers USA Guide, Outstanding Lawyers in America, The International Who's Who of Business Lawyers, The International Who's Who of Life Science Lawyers, The International Who's Who of Products Liability Defense Lawyers, Georgia Trend's "Legal Elite" and Georgia Super Lawyers, including "Top 10 Georgia Super Lawyers" (2013), "Top 100 Georgia Super Lawyers" (2005-2014) and "Top 50 Female Georgia Super Lawyers" (2005-2014), and she is shortlisted in Euromoney Media Group’s Americas Women in Business Awards as one of the "Best in Life Sciences." Lori was one of a very small group of attorneys selected nationally for inclusion in the 2010-2013 editions of Chambers and Partners USA Guide's National Pharmaceutical Industry Products Liability Table.
Lori is highlighted for having a reputation for "using creative approaches to explain to lay jurors complex evidence." In addition to her vast trial experience, she has significant Daubert and scientific expertise with a number of her victories captured in published opinions. She has worked extensively on and lectured nationally regarding the use of technology in courtroom presentations of complex medical, scientific and other catastrophic injury cases.
